Throughout our 60+ year history, our high-quality raw materials created through innovative fermentation and biotechnologies have contributed to the health, beauty and well-being of diverse populations around the globe.

In 1956, we pioneered as the world’s first manufacturer using fermentation for the production of the amino acid L-Glutamic Acid.

Since then, Kyowa has developed many industry-first technologies that continually improve ingredient performance while guaranteeing quality.

1949 Kyowa Hakko Kogyo Co., Ltd. established

1956 Invention of the L-Glutamic Acid production process by fermentation as the first industrial manufacturing process world-wide

1958 Invention of a process for manufacturing L-Lysine by fermentation

1969 Overseas Sales Office Kyowa Hakko U.S.A., Inc. established

1973 Overseas Sales Office Kyowa Hakko Europe GmbH established

1982 Kyowa Italiana Farmaceutici S.r.l. established

1993 Started manufacturing the nucleic acid related compound Citicoline using fermentation

1997 Started manufacturing L-Hydroxyproline after establishing a new manufacturing method

2000 Developed mass production technology for manufacturing sugar chains using fermentation

2004 Started manufacturing Ornithin health food product line

2005 Started manufacturing L-Alanyl-L-Glutamine using fermentation

2007 Kyowa Hakko Kogyo Co., Ltd. acquired Daiichi Fine Chemical Co., Ltd.

2007 Strategic alliance between Kyowa Hakko Group and Kirin Group

2008 Kyowa Hakko Kirin Co., Ltd. established

2008 Kyowa Hakko Bio Co., Ltd. established, taking over the Bio-Chemical business from the Kyowa Hakko Group and Kirin Group alliance.

2010 Kyowa Hakko Bio Italia S.r.l. established as wholly owned subsidiary of Kyowa Hakko Europe GmbH

2015 Daiichi Fine Chemical Co., Ltd. changed its name to Kyowa Pharma Chemical Co., Ltd.